GNI Group Ltd. (2160) Other
Market cap
¥183.8B
P/E ratio
GNI Group develops and manufactures pharmaceuticals and medical devices, serving global markets with key products like Aisuryui in China and biomaterials in the US.
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Return on Assets | - | - | - | - | -9 | -7.7 | -1.7 | -1.3 | 1 | 5.7 | 4 | 1.2 | 16.8 | 1.6 | -5 |
| Return on equity (%) | - | - | - | ||||||||||||
| Employees | 120 | 124 | 123 | 130 | 142 | 183 | 275 | 346 | 458 | 539 | 629 | 701 | 843 | 867 | 990 |
| Total payout ratio | - | - | - | - | - | - | - | - | - | - | 14.2 | - | - | - | - |